Steinberg, H. L., Tropotel, A., Theysohn, J. M., Schaarschmidt, B., Haubold, J., Jeschke, M., . . . Ludwig, J. M. (2025). Evaluation of inflammatory markers as prognostic factors in the treatment of hepatocellular carcinoma (HCC) with degradable starch microspheres by transarterial chemoembolization (DSM-TACE). Cancers, 17(4), . https://doi.org/10.3390/cancers17040647
Chicago Style (17th ed.) CitationSteinberg, Hannah Luisa, Andriana Tropotel, Jens M. Theysohn, Benedikt Schaarschmidt, Johannes Haubold, Matthias Jeschke, Leonie Jochheim, and Johannes Maximilian Ludwig. "Evaluation of Inflammatory Markers as Prognostic Factors in the Treatment of Hepatocellular Carcinoma (HCC) with Degradable Starch Microspheres by Transarterial Chemoembolization (DSM-TACE)." Cancers 17, no. 4 (2025). https://doi.org/10.3390/cancers17040647.
MLA (9th ed.) CitationSteinberg, Hannah Luisa, et al. "Evaluation of Inflammatory Markers as Prognostic Factors in the Treatment of Hepatocellular Carcinoma (HCC) with Degradable Starch Microspheres by Transarterial Chemoembolization (DSM-TACE)." Cancers, vol. 17, no. 4, 2025, https://doi.org/10.3390/cancers17040647.